Search Results - Amitkumar Mehta
- Showing 1 - 9 results of 9
-
1
-
2
-
3
Overall and Cause‐Specific Mortality Among Patients With Cutaneous T‐Cell Lymphoma in the United States by Lauren Shea, Mayur Narkhede, Karthik Chamarti, Tina Gao, Amitkumar Mehta, Gaurav Goyal
Published in eJHaem (2025-04-01)Get full text
Article -
4
P105 NEX-T CD19 chimeric antigen receptor (CAR) T-cell therapy CC-97540 (BMS-986353): Preclinical and translational evidence of deep B-cell depletion suitable for study in severe r... by Georg Schett, Fan Wu, Nikolay Delev, Ruth Salmon, Jerill Thorpe, Amitkumar Mehta, Tatyana Feldman, Jeremy Abramson, Boyu Hu, Fabien Müller, Ashley Koegel, Divya Varun, Alison Maier, David Kugler, Matthew Westoby
Published in Lupus Science and Medicine (2024-03-01)Article -
5
High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes. by Joshua C Anderson, Christopher D Willey, Amitkumar Mehta, Karim Welaya, Dongquan Chen, Christine W Duarte, Pooja Ghatalia, Waleed Arafat, Ankit Madan, Sunil Sudarshan, Gurudatta Naik, William E Grizzle, Toni K Choueiri, Guru Sonpavde
Published in PLoS ONE (2015-01-01)Get full text
Article -
6
Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study by Christopher R. Flowers, Matthew J. Matasar, Alex F. Herrera, Mark Hertzberg, Sarit Assouline, Judit Demeter, Andrew McMillan, Amitkumar Mehta, Stephen Opat, Marek Trnňný, Lisa Musick, Jamie Hirata, Annie Yang, Laurie H. Sehn
Published in Haematologica (2023-09-01)Get full text
Article -
7
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study by Jason Westin, Tycel J. Phillips, Amitkumar Mehta, Marc S. Hoffmann, Eva Gonzalez-Barca, Catherine Thieblemont, Mariana Bastos-Oreiro, Richard Greil, Sebastian Giebel, Michael C. Wei, Jue Wang, Reinhard Bucher, Jason Sit, Elicia Penuel, Enkhtsetseg Purev, Donald L. Yee, Juan Miguel Bergua-Burgues
Published in Blood Advances (2025-05-01)Get full text
Article -
8
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study. by Kai Qin, Kazuhito Honjo, Scott Sherrill-Mix, Weimin Liu, Regina M Stoltz, Allisa K Oman, Lucinda A Hall, Ran Li, Sarah Sterrett, Ellen R Frederick, Jeffrey R Lancaster, Mayur Narkhede, Amitkumar Mehta, Foluso J Ogunsile, Rima B Patel, Thomas J Ketas, Victor M Cruz Portillo, Albert Cupo, Benjamin M Larimer, Anju Bansal, Paul A Goepfert, Beatrice H Hahn, Randall S Davis
Published in PLoS Medicine (2023-06-01)Get full text
Article -
9
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle... by Julie M. Vose, Kai Fu, Lu Wang, Adnan Mansoor, Douglas Stewart, Hongxia Cheng, Lynette Smith, Ji Yuan, Hina Naushad Qureishi, Brian K. Link, Melissa H. Cessna, Paul M. Barr, Brad S. Kahl, Matthew S. Mckinney, Nadia Khan, Ranjana H. Advani, Peter Martin, Andre H. Goy, Tycel J. Phillips, Amitkumar Mehta, Manali Kamdar, Michael Crump, Barbara Pro, Christopher R. Flowers, Caron A. Jacobson, Sonali M. Smith, Deborah M. Stephens, Veronika Bachanova, Zhaohui Jin, Shishou Wu, Francisco Hernandez-Ilizaliturri, Pallawi Torka, Andrea Anampa-Guzmán, Farshid Kashef, Xing Li, Sunandini Sharma, Timothy C. Greiner, James O. Armitage, Matthew Lunning, Dennis D. Weisenburger, Robert G. Bociek, Javeed Iqbal, Guohua Yu, Chengfeng Bi, the North American Mantle Cell Lymphoma Consortium
Published in Journal of Hematology & Oncology (2023-12-01)Get full text
Article
